Sign up to save your podcasts
Or
Share Long Term Efficacy and Safety of Dupilumab for Eosinophilic Esophagitis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Long Term Efficacy and Safety of Dupilumab for Eosinophilic Esophagitis
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swathi Eluri, MD, MS discuss “Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial,” by Summarizing Rothenber M, Dellon E, Collins M, et al. Lancet Gastroenterol Hep. 2023; 9: 990-1004
View all episodes
By American College of Gastroenterology
4.8
1616 ratings
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swathi Eluri, MD, MS discuss “Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial,” by Summarizing Rothenber M, Dellon E, Collins M, et al. Lancet Gastroenterol Hep. 2023; 9: 990-1004
More shows like Evidence-Based GI: An ACG Publication and Podcast
View all
Gut Podcast
7 Listeners
NEJM This Week
319 Listeners
American Journal of Gastroenterology Author Podcasts
71 Listeners
JAMA Clinical Reviews
498 Listeners
The Curbsiders Internal Medicine Podcast
3,326 Listeners
Core IM | Internal Medicine Podcast
1,107 Listeners
The Peter Attia Drive
7,999 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Behind the Case: An ACG Case Reports Journal Podcast
6 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
Listen In: GI Endoscopy
33 Listeners
Gastroenterology Learning Network
10 Listeners
Gastroenterology & Endoscopy
3 Listeners